276. 軟骨無形成症 Achondroplasia Clinical trials / Disease details

臨床試験数 : 51 / 薬物数 : 34 - (DrugBank : 6) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 26

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05353192 (ClinicalTrials.gov)	September 23, 2022	25/4/2022	A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormonein Children With Acho ...	A Multicenter, Open-label, Single Arm Phase IV Clinical Study to Evaluate the Efficacy and Safety of ...	Achondroplasia	Drug: Recombinant human growth hormone	GeneScience Pharmaceuticals Co., Ltd.	Children's Hospital of Fudan University;Tongji Hospital;Children's Hospital of Nanjing Medical Unive ...	Recruiting	2 Years	10 Years	All	38	Phase 4	China
2	NCT01435629 (ClinicalTrials.gov)	November 22, 2012	14/9/2011	A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin	Open-label, Multicenter, Observational, Non-intervention Study to Retrospectively Evaluate the Effic ...	Genetic Disorder;Achondroplasia	Drug: somatropin	Novo Nordisk A/S	NULL	Completed	N/A	N/A	All	81	N/A	Japan
3	NCT01516229 (ClinicalTrials.gov)	May 1, 1997	19/1/2012	Special Survey for Long Term Application	Specific Survey of Norditropin® in Achondroplasia: Survey for Long-term Application	Genetic Disorder;Achondroplasia	Drug: somatropin	Novo Nordisk A/S	NULL	Completed	1 Year	15 Years	All	395	N/A	Japan

First Previous1Next Last